News

Seagate Technology Surpasses Q4 Estimates Amid Cloud Demand

Seagate Technology Surpasses Q4 Estimates Amid Cloud Demand

Seagate Technology Reports Impressive Q4 Results

Seagate Technology Holdings (NASDAQ: STX) announced its fourth-quarter financial results for fiscal 2025, showcasing a robust performance bolstered by continuous demand from cloud customers. This report comes as a beacon of encouragement for investors as the company has outperformed initial revenue forecasts significantly.

Financial Highlights of Q4

Revenue and Earnings

In the fourth quarter, Seagate reported revenues of $2.44 billion, surpassing analyst estimates of $2.42 billion by a slim margin but still emphasizing the company’s strong market position. Adjusted earnings per share (EPS) came in at $2.59, overshadowing initial predictions of $2.43, reflecting effective operational strategies and a committed focus on high-capacity drive products.

Cash Flow Performance

The financial health of Seagate remains steadfast, as the company generated $508 million in cash flow from operations with a free cash flow of $425 million for the quarter. Ending the period, Seagate held $891 million in total cash and cash equivalents, ensuring ample liquidity for future investments and shareholder returns.

CEO Insights on Q4 Performance

Dave Mosley, CEO of Seagate, articulated that the company's performance during the fiscal fourth quarter emphasizes their dedication to profitable growth. He noted, "Our impressive 30% year-over-year revenue increase, coupled with record gross margins, demonstrates the positive trajectory we are on. Our non-GAAP EPS reached the upper limits of our guidance range, highlighting our operational efficiencies."

Future Guidance and Strategic Focus

Looking Ahead

Seagate anticipates that for the upcoming fiscal first quarter, revenues will be between $2.35 billion to $2.65 billion, against predictions of $2.5 billion. The company projects adjusted earnings to range from $2.10 to $2.50 per share, again aligning closely with market expectations but hinting at potential upward fluctuations based on operational advancements.

Dividend Announcement

In an effort to reward shareholders, Seagate’s board declared a quarterly cash dividend of 72 cents per share. This dividend is scheduled to be paid on a future date to shareholders of record, reflecting the company's ongoing commitment to returning value to its investors. With $153 million allocated to cash dividends in the previous quarter, this announcement signals further value generation for stakeholder confidence.

Market Reaction and Share Performance

Following the release of these positive results, Seagate’s stock experienced a downtrend, declining by 7.64% in after-hours trading, pricing at $141.02 during the reporting period. It raises questions regarding market perceptions of the sustainability of current performance amidst broader market conditions.

Conclusion

The remarkable strength exhibited by Seagate Technology in the latest quarter illustrates its resilient business model and effective management strategies. Increased demand from cloud customers has propelled revenue growth, underpinning future opportunities within this lucrative sector. Investors remain cautiously optimistic as they assess the implications of upcoming earnings forecasts and market adaptations in light of evolving technological demands.

Frequently Asked Questions

What were Seagate's Q4 earnings?

Seagate's Q4 earnings were $2.59 per share, exceeding estimates of $2.43.

What was Seagate's revenue for the fourth quarter?

Seagate reported revenues of $2.44 billion in Q4, surpassing the estimate of $2.42 billion.

What is Seagate's dividend for the upcoming quarter?

The company announced a quarterly cash dividend of 72 cents per share.

How much cash flow did Seagate generate?

Seagate generated $508 million in cash flow from operations in the fourth quarter.

What is Seagate's outlook for the next quarter?

Seagate expects next quarter's revenue to be in the range of $2.35 billion to $2.65 billion, with adjusted EPS projected between $2.10 and $2.50.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading